Theriva Biologics, Inc. (TOVX)
About Theriva Biologics, Inc.
Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system. Product Candidates includes SYN-004 (ribaxamase) and SYN-020.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2011
- $0
- Net income
- -$18.3M
- Total assets
- $38.2M
- Market cap
- $11.7M
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $0
- Operating expenses
- $24.1M
- Operating income
- -$24.1M
- Net income
- -$23.7M
- EPS (basic)
- $-2.08
- EPS (diluted)
- $-2.08
Balance sheet
- Total assets
- $38.2M
- Current assets
- $17.5M
- Total liabilities
- $22.9M
- Current liabilities
- $10.0M
- Shareholders’ equity
- $15.4M
Cash flow
- Operating cash flow
- -$16.7M
- Investing cash flow
- -$35.0K
- Financing cash flow
- $18.2M
- Net cash flow
- $1.4M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $11.7M
- EPS (diluted)
- $-2.08
- Shares outstanding
- 53.2M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Apr 5, 1993
Theriva Biologics, Inc. (TOVX) Stock Price
- Reported a net loss of $18.3M in FY2011.
- Trading 74% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Theriva Biologics, Inc..
Write a review
News about Theriva Biologics, Inc.
News & sentiment via Polygon.io
Theriva Biologics, Inc.: frequently asked questions
Is Theriva Biologics, Inc. an American company?
Theriva Biologics, Inc. is a US-based company headquartered in Rockville, Maryland, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Theriva Biologics, Inc. headquartered?
Theriva Biologics, Inc. is headquartered in Rockville, Maryland, United States.
Is Theriva Biologics, Inc. publicly traded?
Yes — Theriva Biologics, Inc. is a publicly traded company. Its stock trades under the ticker symbol TOVX on the NYSE.
What does Theriva Biologics, Inc. do?
Theriva Biologics, Inc. is an American Pharmaceuticals company in the Health & Beauty sector.
